NYMOX-FT Trademark

Trademark Overview

On Monday, November 23, 2020, a trademark application was filed for NYMOX-FT with the United States Patent and Trademark Office. The USPTO has given the NYMOX-FT trademark a serial number of 90337747. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 18, 2024. This trademark is owned by Nymox Pharmaceutical Corporation, Ltd.. The NYMOX-FT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of benign prostatic hyperplasia and prostate cancer
nymox-ft

General Information

Serial Number90337747
Word MarkNYMOX-FT
Filing DateMonday, November 23, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 15, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of benign prostatic hyperplasia and prostate cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 28, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNymox Pharmaceutical Corporation, Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNasau
BS
Party NameNymox Pharmaceutical Corporation, Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNasau
BS

Trademark Events

Event DateEvent Description
Monday, March 18, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 18, 2024ABANDONMENT - NO USE STATEMENT FILED
Friday, August 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 9, 2023SOU EXTENSION 4 GRANTED
Wednesday, August 9, 2023SOU EXTENSION 4 FILED
Wednesday, August 9, 2023SOU TEAS EXTENSION RECEIVED
Saturday, January 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 19, 2023SOU EXTENSION 3 GRANTED
Thursday, January 19, 2023SOU EXTENSION 3 FILED
Thursday, January 19, 2023SOU TEAS EXTENSION RECEIVED
Saturday, August 6, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 4, 2022SOU EXTENSION 2 GRANTED
Thursday, August 4, 2022SOU EXTENSION 2 FILED
Thursday, August 4, 2022SOU TEAS EXTENSION RECEIVED
Thursday, February 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 8, 2022SOU EXTENSION 1 GRANTED
Tuesday, February 8, 2022SOU EXTENSION 1 FILED
Tuesday, February 8, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, August 10, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 15, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 15, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 26, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 12, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 6, 2021ASSIGNED TO EXAMINER
Thursday, January 28, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 26, 2020NEW APPLICATION ENTERED

Related Keywords

nymox hyperplasia prostate cancer prostatic benign preparations treatment pharmaceutical